Neovasc’s Reducer Shows Promise For Refractory Angina
This article was originally published in The Gray Sheet
Executive Summary
In a small but sham-controlled trial Neovasc’s balloon-expandable implant significantly improved symptoms and quality of life in patients with refractory angina who are not candidates for other revascularization procedures. Reducer works by increasing pressure in the coronary sinus.